Correlation Between Humacyte and LMF Acquisition

Can any of the company-specific risk be diversified away by investing in both Humacyte and LMF Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Humacyte and LMF Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Humacyte and LMF Acquisition Opportunities, you can compare the effects of market volatilities on Humacyte and LMF Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Humacyte with a short position of LMF Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Humacyte and LMF Acquisition.

Diversification Opportunities for Humacyte and LMF Acquisition

0.53

Correlation Coefficient

Humacyte  LMF Acquisition

Very weak diversification

The 3 months correlation between Humacyte and LMF is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Humacyte and LMF Acquisition Opportunities in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LMF Acquisition Oppo and Humacyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Humacyte are associated (or correlated) with LMF Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LMF Acquisition Oppo has no effect on the direction of Humacyte i.e., Humacyte and LMF Acquisition go up and down completely randomly.

Pair Corralation between Humacyte and LMF Acquisition

Assuming the 90 days horizon Humacyte is expected to generate 0.68 times more return on investment than LMF Acquisition. However, Humacyte is 1.47 times less risky than LMF Acquisition. It trades about 0.05 of its potential returns per unit of risk. LMF Acquisition Opportunities is currently generating about -0.01 per unit of risk. If you would invest  171.00  in Humacyte on September 23, 2024 and sell it today you would earn a total of  3.00  from holding Humacyte or generate 1.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Humacyte  vs.  LMF Acquisition Opportunities

Humacyte

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Humacyte are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Humacyte showed solid returns over the last few months and may actually be approaching a breakup point.

LMF Acquisition Oppo

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days LMF Acquisition Opportunities has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's fundamental indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Humacyte and LMF Acquisition

The main advantage of trading using opposite Humacyte and LMF Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Humacyte position performs unexpectedly, LMF Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LMF Acquisition will offset losses from the drop in LMF Acquisition's long position.

The idea behind Humacyte and LMF Acquisition Opportunities pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.